Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Open Studies | "Mixed Connective Tissue Disease"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Mixed Connective Tissue Disease" (4 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
Conditions: Mixed Connective Tissue Disease (MCTD);   Systemic Lupus Erythematosus (SLE)
Intervention:
2 Recruiting Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome
Conditions: Systemic Lupus Erythematosus;   Rheumatoid Arthritis;   Sharp's Syndrome
Interventions: Other: Intravenous injection of Stromal Vascular Fraction Cells (SVF) containing ADSCs;   Other: Lipoaspiration
3 Not yet recruiting Role of Mesenchymal Stem Cells in Fat Grafting
Conditions: Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
4 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years